Craig Dais serves as Executive at NAVIDEA BIOPHARMACEUTICALS, INC., where they oversee executive responsibilities. Since joining the company, Craig Dais has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Nov 10, 2023 involved receiving (via award) 973,633 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Nov 10, 2023 | NAVB | $0 | Award | 973,633 | $N/A | Discretionary |
Craig Dais currently holds 973,633 shares of NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Craig Dais has been a net neutral trader of NAVB stock. They have purchased $0 and sold $0 worth of shares.
Craig Dais's most recent insider trade was on Nov 10, 2023, when they sold 973,633 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted